spacer
home >
PUBLICATIONS

 
 
 
Featured in this issue

Maintaining Control

Anna Lukyanova at Arriello

Pharma and biotech companies should take care not to neglect the role of formal project management in process outsourcing.

A Scalable Solution

Susan Najjar at Covance

It is important for smaller enterprises to seek specialised clinical and regulatory support in order to streamline pre- and post-marketing phases.

 

 
Paving the Way

Rik Van Mol at Veeva Systems

In order to drive efficiency and a faster time to market, sponsors, CROs, and pharma companies need to embrace collaboration.

spacer

 

 
News and Press Releases

Joining forces against SARS-CoV-2

Laupheim, Germany and Milford, MA, USA, October 08, 2020 - Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced an agreement to serve as CDMO partner for BioNTech. As an initial project, Rentschler Biopharma will be responsible for key aspects of cGMP (current good manufacturing practice) drug substance manufacturing of BNT162b2, the mRNA-based vaccine against SARS-CoV-2 that is being developed by Pfizer and BioNTech, and is currently in a global Phase 3 clinical trial.
More info >>

 
White Papers

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement